Personas / Equipo Humano

Bru Cormand Rifà

Buscador de publicaciones

Publicaciones

  • Leggieri A, García-González J, Hosseinian S, Ashdown P, Anagianni S, Wang X, Havelange W, Fernandez-Castillo N, Cormand B and Brennan CH.

    rbfox1 loss of function in zebrafish leads to dysregulation in bdnf/trkb2 and pac1a expression resulting in HPI axis hyperactivation, altered stress response and allostatic overload.

    Biorxiv . : .

    [doi:10.1101/2024.10.09.616976]

  • Zillich E, Belschner H, Avetyan D, Andrade-Brito D, Martínez-Magaña JJ, Frank J, Mechawar N, Turecki G, Cabana-Domínguez J, Fernandez-Castillo N, Cormand B, Montalvo-Ortiz JL, Nöthen MM, Hansson AC, Rietschel M, Spanagel R, Witt SH and Zillich L.

    Multi-omics profiling of DNA methylation and gene expression alterations in human cocaine use disorder.

    TRANSLATIONAL PSYCHIATRY . 14(1): 428-428.

    [doi:10.1038/s41398-024-03139-9]

  • Samulenaite S, García-Blanco A, Mayneris-Perxachs J, Domingo-Rodríguez L, Cabana-Domínguez J, Fernandez-Castillo N, Gago-García E, Pineda L, Burokas A, Espinosa-Carrasco J, Arboleya S, Latorre J, Stanton C, Hosomi K, Kunisawa J, Cormand B, Fernández-Real JM, Maldonado R and Martín-García E.

    Gut microbiota signatures of vulnerability to food addiction in mice and humans.

    Gut . 73(11): 1799-1815. Nº de citas: 2

    [doi:10.1136/gutjnl-2023-331445]

  • Vilar-Ribó L, Cabana-Domínguez J, Alemany S, Llonga N, Arribas L, Grau-López L, Daigre C, Cormand B, Fernandez-Castillo N, Ramos-Quiroga JA, Soler Artigas M and Ribasés M.

    Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores

    TRANSLATIONAL PSYCHIATRY . 14(1): 221-221.

    [doi:10.1038/s41398-024-02923-x]

  • Koller D, Mitjans M, Kouakou M, Friligkou E, Cabrera-Mendoza B, Deak JD, Llonga N, Pathak GA, Stiltner B, Løkhammer S, Levey DF, Zhou H, Hatoum AS, Kember RL, Kranzler HR, Stein MB, Corominas R, Demontis D, Artigas MS, Ramos-Quiroga JA, Gelernter J, Ribasés M, Cormand B and Polimanti R.

    Genetic contribution to the comorbidity between attention-deficit/ hyperactivity disorder and substance use disorders

    PSYCHIATRY RESEARCH . 333: 115758-115758. Nº de citas: 1

    [doi:10.1016/j.psychres.2024.115758]

  • Antón-Galindo E, Adel MR, García-González J, Leggieri A, López-Blanch L, Irimia M, Norton WHJ, Brennan CH, Fernandez-Castillo N and Cormand B.

    Pleiotropic contribution of rbfox1 to psychiatric and neurodevelopmental phenotypes in two zebrafish models

    TRANSLATIONAL PSYCHIATRY . 14(1): 99-99. Nº de citas: 3

    [doi:10.1038/s41398-024-02801-6]

  • Adel MR, Antón-Galindo E, Gago-Garcia E, Arias-Dimas A, Arenas C, Artuch-Iriberri R, Cormand B and Fernandez-Castillo N.

    Decreased Brain Serotonin in rbfox1 Mutant Zebrafish and Partial Reversion of Behavioural Alterations by the SSRI Fluoxetine

    Pharmaceuticals . 17(2): .

    [doi:10.3390/ph17020254]

  • Antón-Galindo E, Cabana-Domínguez J, Torrico B, Corominas R, Cormand B and Fernandez-Castillo N.

    The pleiotropic contribution of genes in dopaminergic and serotonergic pathways to addiction and related behavioral traits

    Frontiers in Psychiatry . 14: 1293663-1293663. Nº de citas: 3

    [doi:10.3389/fpsyt.2023.1293663]

  • Ribasés M, Mitjans M, Hartman CA, Soler Artigas M, Demontis D, Larsson H, Ramos-Quiroga JA, Kuntsi J, Faraone SV, Børglum AD, Reif A, Franke B and Cormand B.

    Genetic architecture of ADHD and overlap with other psychiatric disorders and cognition-related phenotypes

    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS . 153: 105313-105313. Nº de citas: 4

    [doi:10.1016/j.neubiorev.2023.105313]

  • Hartman CA, Chen Q, Solberg BS, Du Rietz E, Klungsøyr K, Cortese S, Dalsgaard S, Haavik J, Ribasés M, Mostert JC, Libutzki B, Kittel-Schneider S, Cormand B, Vos M, Larsson H, Reif A, Faraone SV and Bellato A.

    Anxiety, mood, and substance use disorders in adult men and women with and without attention-deficit/hyperactivity disorder: A substantive and methodological overview

    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS . 151: 105209-105209. Nº de citas: 20

    [doi:10.1016/j.neubiorev.2023.105209]